BioGaia® Gastrus contains Lactobacillus reuteri DSM 17938 + Lactobacillus reuteri ATCC PTA 6475, sourced from human origin.

Features 

Targeted support with this unique Lactobacillus reuteri strain combination.

Formulation notes: 

• Contains only probiotic strains of human origin: Lactobacillus reuteri DSM 17938 + Lactobacillus reuteri ATCC PTA 6475 (both strains isolated from breast milk)
• Provides evidence-based probiotic strains with clinical data to support their use.
• Delivers probiotic strains that survive transit through gastrointestinal (GI) tract without significant loss of potency (CFUs).
• Contains two probiotic strains shown to colonise the GI tract and adhere strongly to mucosal layer.
• Ensure only complementary probiotic strains are combined for optimal efficacy.
• Delivers a scientifically validated daily dose of 200 million organisms (CFUs) in a convenient one-a-day dose.
• Does not require refrigeration, for ease of use and convenience.
• Sweetened with xylitol.

Ingredients 

Each BioGaia® Gastrus chewable tablet contains:
Lactobacillus reuteri (DSM 17938) +	100 million organisms (CFUs)
Lactobacillus reuteri (ATCC PTA 6475)	100 million organisms (CFUs)

 

Excipients:

• Isomalt
• Sustainably sourced fully hydrogenated palm oil
• Ascorbic acid
• Calcium stearate
• Mandarin flavouring
• Mint flavouring

• Vegetarian formula.
• No added: wheat, yeast, soy, dairy and animal products, lactose, egg, nuts, artificial colours, flavours, or preservatives, magnesium stearate or SLS.

Directions for Use 

Adults & children: Consume 1 chewable tablet daily, with meals, or as directed by your healthcare professional.

Cautions 

• Use only as directed and if symptoms persist consult your health professional.
• For practitioner dispensing only.